NL-OMON36047
Recruiting
Not Applicable
Pilot study using Fluorine-18 Sodium Fluoride PET/CT in diagnosing of skeletal metastases in men with prostate cancer. - Pilotstudy Sodium Fluoride PET/CT
Isala Klinieken0 sites90 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- metastases
- Sponsor
- Isala Klinieken
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •De novo prostate cancer, and
- •Informed consent, and
- •indication for bone scintigraphy
Exclusion Criteria
- •oncologic history, and
- •on hormon treatment, and
- •unable to tolerate PET/CT
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1EUCTR2009-016523-61-GBKing’s College London30
Completed
Phase 2
F-18 Sodium Fluoride in Prostate CancerProstate NeoplasmNCT01240551National Cancer Institute (NCI)60
Active, not recruiting
Not Applicable
Phase III clinical study of PET-TC with [18f]Fluoroethyilcholine ([18f]Fech) in prostate cancer: assessment of the additional role with respec to conventional imaging techniquesprostate cancerMedDRA version: 14.1Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]EUCTR2012-004297-26-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI750
Recruiting
Phase 2
FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade GliomaGlioma, MalignantNCT06172595Singapore General Hospital22
Completed
Phase 2
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone MetastasesHormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate CarcinomaStage IV Prostate CancerNCT00936975National Cancer Institute (NCI)18